Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258–70.


Google Scholar 

Castle EM, Greenwood SA, Müller RU. The importance of lifestyle interventions in the prevention and treatment of chronic kidney disease. Kidney Dial. 2023;3(2):192–5.


Google Scholar 

Wang L, Xu X, Zhang M, Hu C, Zhang X, Li C, et al. Prevalence of chronic kidney disease in China: results from the sixth China chronic disease and risk factor surveillance. JAMA Intern Med. 2023;183(4):298–310.


Google Scholar 

Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383(15):1436–46.


Google Scholar 

Zoccali C, Mark PB, Sarafidis P, Agarwal R, Adamczak M, de Bueno R, et al. Diagnosis of cardiovascular disease in patients with chronic kidney disease. Nat Rev Nephrol. 2023;19(11):733–46.


Google Scholar 

Shajahan S, Amin J, Phillips JK, Hildreth CM. Relationship between sex and cardiovascular mortality in chronic kidney disease: A systematic review and meta-analysis. PLoS ONE. 2021;16(7):e0254554.


Google Scholar 

Swartling O, Rydell H, Stendahl M, Segelmark M, Trolle Lagerros Y, Evans M. CKD progression and mortality among men and women: A nationwide study in Sweden. Am J Kidney Dis. 2021;78(2):190–e1991.


Google Scholar 

Wang V, Vilme H, Maciejewski ML, Boulware LE. The economic burden of chronic kidney disease and End-Stage renal disease. Semin Nephrol. 2016;36(4):319–30.


Google Scholar 

Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):S47–64.


Google Scholar 

Targher G, Byrne CD, Tilg H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and Pharmacological implications. Gut. 2020;69(9):1691–705.


Google Scholar 

Petrov MS, Taylor R. Intra-pancreatic fat deposition: bringing hidden fat to the fore. Nat Rev Gastroenterol Hepatol. 2022r;19(3):153–68.


Google Scholar 

Caldart F, de Pretis N, Luchini C, Ciccocioppo R, Frulloni L. Pancreatic steatosis and metabolic pancreatic disease: a new entity? Intern Emerg Med. 2023;18(8):2199–208.


Google Scholar 

Olivero A, Basso L, Barabino E, Milintenda P, Testino N, Chierigo F, et al. The impact of visceral adipose tissue on postoperative renal function after radical nephrectomy for renal cell carcinoma. Minerva Urol Nephrol. 2021;73(6):789–95.


Google Scholar 

Bilson J, Mantovani A, Byrne CD, Targher G. Steatotic liver disease, MASLD and risk of chronic kidney disease. Diabetes Metab. 2024;50(1):101506.


Google Scholar 

Sun DQ, Jin Y, Wang TY, Zheng KI, Rios RS, Zhang HY, et al. MAFLD and risk of CKD. Metabolism. 2021;115:154433.


Google Scholar 

Wang TY, Wang RF, Bu ZY, Targher G, Byrne CD, Sun DQ, et al. Association of metabolic dysfunction-associated fatty liver disease with kidney disease. Nat Rev Nephrol. 2022;18(4):259–68.


Google Scholar 

Wang Z, do Carmo JM, da Silva AA, Fu Y, Hall JE. Mechanisms of synergistic interactions of diabetes and hypertension in chronic kidney disease: role of mitochondrial dysfunction and ER stress. Curr Hypertens Rep. 2020;22(2):15.


Google Scholar 

Olesen SS, Poulsen JL, Novovic S, Nøjgaard C, Kalaitzakis E, Jensen NM, et al. Multiple risk factors for diabetes mellitus in patients with chronic pancreatitis: A multicentre study of 1117 cases. United Eur Gastroenterol J. 2020;8(4):453–61.


Google Scholar 

Zhang Y, Liu Y, Petrov MS. Relationship of fat in the pancreas with cardiovascular disease: A systematic review and meta-analysis. Obes Rev. 2025;26(7):e13914.


Google Scholar 

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.

Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New Creatinine- and Cystatin C-Based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737–49.


Google Scholar 

Ramkissoon R, Gardner TB. Pancreatic steatosis: an emerging clinical entity. Am J Gastroenterol. 2019;114(11):1726–34.


Google Scholar 

Wagner R, Eckstein SS, Yamazaki H, Gerst F, Machann J, Jaghutriz BA, et al. Metabolic implications of pancreatic fat accumulation. Nat Rev Endocrinol. 2022;18(1):43–54.


Google Scholar 

Yamazaki H, Streicher SA, Wu L, Fukuhara S, Wagner R, Heni M, et al. Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mendelian randomization study. Cell Rep Med. 2024;5:101391.


Google Scholar 

Gao J, Li Y, Zhang Y, Zhan X, Tian X, Li J, et al. Severity and remission of metabolic Dysfunction–Associated Fatty/Steatotic liver disease with chronic kidney disease occurrence. J Am Heart Assoc. 2024;13(5):e032604.


Google Scholar 

Wei S, Song J, Xie Y, Huang J, Yang J. Metabolic dysfunction-associated fatty liver disease can significantly increase the risk of chronic kidney disease in adults with type 2 diabetes. Diabetes Res Clin Pract. 2023;197:110563.


Google Scholar 

Yang M, Geng CA, Liu X, Guan M. Lipid disorders in NAFLD and chronic kidney disease. Biomedicines. 2021;9(10):1405.


Google Scholar 

Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease. Clin J Am Soc Nephrol CJASN. 2017;12(12):2032–45.


Google Scholar 

Zhang L, Long J, Jiang W, Shi Y, He X, Zhou Z, et al. Trends in chronic kidney disease in China. N Engl J Med. 2016;375(9):905–6.


Google Scholar 

Mihai S, Codrici E, Popescu ID, Enciu AM, Albulescu L, Necula LG, et al. Inflammation-Related mechanisms in chronic kidney disease Prediction, Progression, and outcome. J Immunol Res. 2018;2018:2180373.


Google Scholar 

Tsai YW, Chan YL, Chen YC, Cheng YH, Chang SS. Association of elevated blood serum high-sensitivity C-reactive protein levels and body composition with chronic kidney disease: A population-based study in Taiwan. Med (Baltim). 2018;97(36):e11896.


Google Scholar 

Singh RG, Nguyen NN, Cervantes A, Alarcon Ramos GC, Cho J, Petrov MS. Associations between intra-pancreatic fat deposition and Circulating levels of cytokines. Cytokine. 2019;120:107–14.


Google Scholar 

Trudeau KM, Colby AH, Zeng J, Las G, Feng JH, Grinstaff MW, et al. Lysosome acidification by photoactivated nanoparticles restores autophagy under lipotoxicity. J Cell Biol. 2016;214(1):25–34.


Google Scholar 

Ren J, Pulakat L, Whaley-Connell A, Sowers JR. Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J Mol Med Berl Ger. 2010;88(10):993–1001.


Google ScholarÂ